Use autologous cSVF + MSCs (cryo) for management of autoimmune component, anti-inflammatory and immune modulation
GARM-Autism Adults
Phase 2 mab active
Quick answer
Use autologous cSVF + MSCs (cryo) for management of autoimmune component, anti-inflammatory and immune modulation for Autism Spectrum Disorder is a Phase 2 program (mab) at Black Diamond Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Black Diamond Therapeutics
- Indication
- Autism Spectrum Disorder
- Phase
- Phase 2
- Modality
- mab
- Status
- active